Overall Technical outlook

Price Summary

J. B. Chemicals & Pharmaceuticals Limited's stock skyrocketed 2.16% today, reflecting an stellarnding market day.
On 2026-01-30, JBCHEPHARM's stock started at 1830.0, reached a high of 1883.1, fell to 1775.8, and ended 2.16% higher at 1869.5, with 146948 shares traded.
The stock reached its highest price of 1933.0 and its lowest price of 1504.4 during the 52-week period.
12 analysts predict that the future price of JBCHEPHARM will be in the range of 1752.0 to 2320.0, with a mean expected price of about 2121.5833.

Technicals

Support and Resistance: The price of 1869.5 is supported at 1828.4 and capped by resistance at 1933.0. These levels mark key points for J. B. Chemicals & Pharmaceuticals Limited where the price could find stability, with 1828.4 as a floor and 1933.0 as a ceiling.
JBCHEPHARM supportResistance 6fc1e0
Support/Resistance for JBCHEPHARM


Aroon: Aroon's bearish trend persists, with Aroon Down staying at the 100 level. This consistent bearish momentum suggests further declines, but a more detailed analysis using other indicators is necessary to confirm the trend's future direction.
JBCHEPHARM aroon 6fc1e0
Aroon chart for J. B. Chemicals & Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for J. B. Chemicals & Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
JBCHEPHARM bbands 6fc1e0
Bolinger Bands chart for J. B. Chemicals & Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for JBCHEPHARM.
JBCHEPHARM psar 6fc1e0
Parabolic Stop and Reverse chart for J. B. Chemicals & Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
JBCHEPHARM stoch 6fc1e0
Stochastic chart for J. B. Chemicals & Pharmaceuticals Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the slopes of the 20 and 50 SMAs are beginning to waver. This weakening in downward momentum could signal a potential shift towards bullish price action. Investors might interpret this as an early indication that the market is preparing for a reversal, with the possibility of a bullish trend emerging soon.
JBCHEPHARM trippleSMA 6fc1e0
Tripple SMA chart for J. B. Chemicals & Pharmaceuticals Limited


To properly assess the technical data of a company, it's important to first look at its fundamentals, such as its earnings, growth potential, and management effectiveness. Equally, understanding the industry trends, competition, and external economic factors that influence the company is vital. This holistic view helps draw meaningful conclusions about the company's technical performance, allowing investors to better gauge its stock price behavior, volatility, and market trends.